Have a personal or library account? Click to login

References

  1. 1Thienemann F, Pinto F, Grobbee DE, et al. World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries. Glob Heart. 2020; 15(1): 31. [published Online first: 4 June 2020]. DOI: 10.5334/gh.778
  2. 2Hopman J, Allegranzi B, Mehtar S. Managing COVID-19 in Low- and Middle-Income Countries. JAMA. 2020; 323(16): 154950. [published Online first: 17 March 2020]. DOI: 10.1001/jama.2020.4169
  3. 3Angrup A, Kanaujia R, Ray P, et al. Healthcare facilities in low- and middle-income countries affected by COVID-19: Time to upgrade basic infection control and prevention practices. Indian J Med Microbiol. 2020; 38(2): 13943. [published Online first: 05 September 2020]. DOI: 10.4103/ijmm.IJMM_20_125
  4. 4Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020; 180(10): 134555. [published Online first: 16 July 2020]. DOI: 10.1001/jamainternmed.2020.3539
  5. 5Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8): 78293. [published Online first: 11 July 2020]. DOI: 10.1001/jama.2020.12839
  6. 6O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021; 590(7844): 14045. [published Online first: 3 November 2020]. DOI: 10.1038/s41586-020-2918-0
  7. 7Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases. 2020; 20(6): 66977. DOI: 10.1016/S1473-3099(20)30243-7
  8. 8Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med J. 2021; 97(1147): 31220. [published Online first: 27 September 2020]. DOI: 10.1136/postgradmedj-2020-138577
  9. 9Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020; 8(5): 47581. DOI: 10.1016/S2213-2600(20)30079-5
  10. 10Xiong T-Y, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur Heart J. 2020; 41(19): 1798800. DOI: 10.1093/eurheartj/ehaa231
  11. 11Alharthy A, Aletreby W, Faqihi F, et al. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study. J Epidemiol Glob Health. 2021; 11(1): 98104. [published Online first: 24 October 2020]. DOI: 10.2991/jegh.k.200928.001
  12. 12Adu-Amankwaah J, Mprah R, Adekunle AO, et al.The cardiovascular aspect of COVID-19. Ann Med. 2021; 53(1): 22736. [published Online first: 22 December 2020]. DOI: 10.1080/07853890.2020.1861644
  13. 13Sliwa K, Singh K, Raspail L, et al. The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease. Glob Heart. 2021; 16(1): 22. [published Online first: 28 May 2021]. DOI: 10.5334/gh.950
  14. 14Bank W. Poverty and Shared Prosperity 2020: Reversals of Fortune. 2020.
  15. 15Bukhman G, Mocumbi AO, Atun R, et al. The Lancet NCDI Poverty Commission: Bridging a gap in universal health coverage for the poorest billion. The Lancet. 2020; 396(10256): 9911044. DOI: 10.1016/S0140-6736(20)31907-3
  16. 16World Bank county classification by income. (Accessed 04 January 2022). https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
  17. 17Alkmim MB, Silva CBG, Figueira RM, et al. Brazilian National Service of Telediagnosis in Electrocardiography. Stud Health Technol Inform. 2019; 264: 163536. [published Online first: 24 August 2019]. DOI: 10.3233/shti190571
  18. 18Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 37781. [published Online first: 22 October 2008]. DOI: 10.1016/j.jbi.2008.08.010
  19. 19Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. [published Online first: 13 May 2019]. DOI: 10.1016/j.jbi.2019.103208
  20. 20Karp I. Re: ‘Estimating the relative risk in cohort studies and clinical trials of common outcomes’. Am J Epidemiol. 2014; 179(8): 10345. [published Online first: 21 February 2014]. DOI: 10.1093/aje/kwt435
  21. 21McNutt LA, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003; 157(10): 9403. [published Online first: 15 May 2003]. DOI: 10.1093/aje/kwg074
  22. 22Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159(7): 7026. [published Online first: 23 March2004]. DOI: 10.1093/aje/kwh090
  23. 23Dai CL, Kornilov SA, Roper RT, et al. Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity. Clin Infect Dis; 2021. [published Online first: 21 February 2021]. DOI: 10.1093/cid/ciab154
  24. 24Acosta AM, Garg S, Pham H, et al. Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021. JAMA Netw Open. 2021; 4(10): e2130479. [published Online first: 22 October 2021]. DOI: 10.1001/jamanetworkopen.2021.30479
  25. 25Qureshi AI, Baskett WI, Huang W, et al. Effect of Race and Ethnicity on In-Hospital Mortality in Patients with COVID-19. Ethn Dis. 2021; 31(3): 38998. [published Online first: 24 July 2021]. DOI: 10.18865/ed.31.3.389
  26. 26Xiong TY, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur Heart J. 2020; 41(19): 1798800. [published Online first: 19 March 2020]. DOI: 10.1093/eurheartj/ehaa231
  27. 27Behrouzi B, Araujo Campoverde MV, Liang K, et al. Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 76(15): 177794. [published Online first: 10 October 2020]. DOI: 10.1016/j.jacc.2020.08.028
  28. 28Yedlapati SH, Khan SU, Talluri S, et al. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2021; 10(6): e019636. [published Online first: 16 March 2021]. DOI: 10.1161/JAHA.120.019636
  29. 29Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis. JAMA. 2013; 310(16): 171120. [published Online first: 24 October 2013]. DOI: 10.1001/jama.2013.279206
  30. 30Verma S, Saksena S, Sadri-Ardekani H. ACE2 receptor expression in testes: Implications in coronavirus disease 2019 pathogenesisdagger. Biol Reprod. 2020; 103(3): 44951. [published Online first: 20 May 2020]. DOI: 10.1093/biolre/ioaa080
  31. 31Al-Benna S. Angiotensin-converting enzyme 2 gene expression in human male urological tissues: implications for pathogenesis and virus transmission pathways. Afr J Urol. 2021; 27(1): 89. [published Online first: 8 July 2021]. DOI: 10.1186/s12301-021-00192-4
  32. 32Prabhakaran D, Chandrasekaran AM, Singh K, et al. Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial. J Am Coll Cardiol. 2020; 75(13): 155161. [published Online first: 4 April 2020]. DOI: 10.1016/j.jacc.2020.01.050
  33. 33Dhakal BP, Sweitzer NK, Indik JH, et al. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ. 2020; 29(7): 97387. [published Online first: 1 July 2020]. DOI: 10.1016/j.hlc.2020.05.101
  34. 34Nishiga M, Wang DW, Han Y, et al. COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17(9): 54358. [published Online first: 22 July 2020]. DOI: 10.1038/s41569-020-0413-9
  35. 35Ma L, Song K, Huang Y. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. J Cardiothorac Vasc Anesth. 2021; 35(6): 186065. [published Online first: 27 May 2020]. DOI: 10.1053/j.jvca.2020.04.041
  36. 36Chang WT, Toh HS, Liao CT, et al. Cardiac Involvement of COVID-19: A Comprehensive Review. Am J Med Sci. 2021; 361(1): 1422. [published Online first: 15 November 2020]. DOI: 10.1016/j.amjms.2020.10.002
  37. 37Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology. 2020; 5(7): 80210. DOI: 10.1001/jamacardio.2020.0950
  38. 38Pareek M, Singh A, Vadlamani L, et al. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry). Am J Cardiol. 2021; 146: 99106. [published Online first: 5 February 2021]. DOI: 10.1016/j.amjcard.2021.01.029
  39. 39Mehraeen E, Karimi A, Barzegary A, et al. Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med. 2020; 40: 101226. [published Online first: 27 October 2020]. DOI: 10.1016/j.eujim.2020.101226
  40. 40Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020; 369: m1328. [published Online first: 9 April2020]. DOI: 10.1136/bmj.m1328
  41. 41Zhang JJY, Lee KS, Ang LW, et al. Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Clin Infect Dis. 2020; 71(16): 2199206. [published Online first: 15 May 2020]. DOI: 10.1093/cid/ciaa576
  42. 42Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, et al. Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020; 15(11): e0241742. [published Online first: 4 November 2020]. DOI: 10.1371/journal.pone.0241742
  43. 43Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020; 130(4): 30409. [published Online first: 2 April 2020]. DOI: 10.20452/pamw.15272
  44. 44Mubarik S, Liu X, Eshak ES, et al. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study. Front Med (Lausanne). 2021; 8: 623608. [published Online first: 1 June 2021]. DOI: 10.3389/fmed.2021.623608
  45. 45Bian J, Li Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm Sin B. 2021; 11(1): 112. [published Online first: 20 October 2020]. DOI: 10.1016/j.apsb.2020.10.006
  46. 46Wu J, Deng W, Li S, et al. Advances in research on ACE2 as a receptor for 2019-nCoV. Cell Mol Life Sci. 2021; 78(2): 53144. [published Online first: 12 August 2020]. DOI: 10.1007/s00018-020-03611-x
DOI: https://doi.org/10.5334/gh.1128 | Journal eISSN: 2211-8179
Language: English
Submitted on: Mar 13, 2022
Accepted on: May 19, 2022
Published on: Jun 15, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, Lana Raspail, Bishav Mohan, Toru Kato, Nizal Sarrafzadegan, Shamim Hayder Talukder, Shahin Akter, Mohammad Robed Amin, Fastone Goma, Juan Gomez-Mesa, Ntobeko Ntusi, Francisca Inofomoh, Surender Deora, Evgenii Philippov, Alla Svarovskaya, Alexandra Konradi, Aurelio Puentes, Okechukwu S. Ogah, Bojan Stanetic, Aurora Issa, Friedrich Thienemann, Dafsah Juzar, Ezequiel Zaidel, Sana Sheikh, Dike Ojji, Carolyn S.P. Lam, Junbo Ge, Amitava Banerjee, L. Kristin Newby, Antonio Luiz P. Ribeiro, Samuel Gidding, Fausto Pinto, Pablo Perel, Karen Sliwa, On Behalf of the WHF COVID-19 Study Collaborators, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.